Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept

Fig. 1

Achievement of sustained Clinical Disease Activity Index (CDAI) low disease activity (LDA). A Proportion of patients with sustained CDAI LDA; B Time to achievement of sustained CDAI LDA. *P-value was based on the clustered-corrected (Rao-Scott) Chi-square test. **P-value was based on Cox proportional hazard model adjusted for site (random effect), month, prior biologic disease-modifying antirheumatic drug exposure, site size, and smoking status. Crosses indicate censoring. CI: confidence interval; HR: hazard ratio; RC: routine care; T2T: treat-to-target

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us